Improvement of Quality of Life by Switching from Oral Semaglutide to Tirzepatide in Patients with Type 2 Diabetes
Switching from oral semaglutide to tirzepatide potentially improves overall QOL in patients with T2DM in a short period of time. Further large cohort studies will reinforce the results.
Authors
- Fumiaki Ishibashi (ORCID: https://orcid.org/0000-0003-4065-7958)
- Takahiro Fukaishi
Institutions
- Diabetes Australia (AU)
- Ichikawa City Rehabilitation Hospital (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- JMA Journal
- Published
- 2025-01-01
- DOI
- https://doi.org/10.31662/jmaj.2025-0011
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29